Published in J Med Genet on July 05, 2009
Management of cytomegalovirus infection in solid organ transplantation. Nat Rev Nephrol (2010) 1.12
CD28 family and chronic rejection: "to belatacept...And beyond!". J Transplant (2012) 0.82
Cytomegalovirus infection in transplant recipients. Clinics (Sao Paulo) (2015) 0.80
Cytomegalovirus Reinfections Stimulate CD8 T-Memory Inflation. PLoS One (2016) 0.78
CTLA4 gene polymorphisms influence the incidence of infection after renal transplantation in Chinese recipients. PLoS One (2013) 0.76
Risk of infectious diseases among first-degree relatives of transplant recipients who develop CMV infection: is the infectious phenotype inheritable? Eur J Clin Microbiol Infect Dis (2017) 0.75
Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med (2008) 3.85
Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol (2013) 2.47
Kidney and recipient weight incompatibility reduces long-term graft survival. J Am Soc Nephrol (2010) 2.08
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood (2005) 1.99
Early low-grade proteinuria: causes, short-term evolution and long-term consequences in renal transplantation. Am J Transplant (2005) 1.82
A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. J Am Soc Nephrol (2003) 1.77
One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial. Transplantation (2016) 1.68
Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score. J Clin Oncol (2013) 1.50
Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins. J Med Microbiol (2004) 1.32
Hepatitis C virus-like particle morphogenesis. J Virol (2002) 1.32
Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine (Baltimore) (2012) 1.31
Both expansion of regulatory GR1+ CD11b+ myeloid cells and anergy of T lymphocytes participate in hyporesponsiveness of the lung-associated immune system during acute toxoplasmosis. Infect Immun (2004) 1.31
Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J Allergy Clin Immunol (2006) 1.22
Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. J Hypertens (2006) 1.21
Novel human reovirus isolated from children with acute necrotizing encephalopathy. Emerg Infect Dis (2011) 1.14
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. Transplantation (2003) 1.13
Replacement kidney lipomatosis after renal transplantation. Transplantation (2005) 1.12
Drug-resistant cytomegalovirus in transplant recipients: a French cohort study. J Antimicrob Chemother (2010) 1.10
Genetic heterogeneity of the NS3 protease gene in hepatitis C virus genotype 1 from untreated infected patients. J Med Virol (2005) 1.08
Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients. Clin Pharmacokinet (2004) 1.05
Acute renal allograft rejections with major interstitial oedema and plasma cell-rich infiltrates: high gamma-interferon expression and poor clinical outcome. Nephrol Dial Transplant (2004) 1.03
A clinical scoring system highly predictive of long-term kidney graft survival. Kidney Int (2010) 1.03
Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology. Drugs (2010) 1.03
Quantification of interstitial fibrosis by image analysis on routine renal biopsy in patients receiving cyclosporine. Transplantation (2007) 1.02
Correction of postkidney transplant anemia reduces progression of allograft nephropathy. J Am Soc Nephrol (2011) 1.02
Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation. Transpl Int (2008) 1.01
TLR9 activation induces normal neutrophil responses in a child with IRAK-4 deficiency: involvement of the direct PI3K pathway. J Immunol (2007) 1.01
High burden of non-influenza viruses in influenza-like illness in the early weeks of H1N1v epidemic in France. PLoS One (2011) 1.01
Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy. Clin Transplant (2003) 1.01
A double absorption-phase model adequately describes mycophenolic acid plasma profiles in de novo renal transplant recipients given oral mycophenolate mofetil. Clin Pharmacokinet (2005) 1.01
The methylerythritol phosphate pathway for isoprenoid biosynthesis in coccidia: presence and sensitivity to fosmidomycin. Exp Parasitol (2007) 1.00
Respective predictive role of urinary albumin excretion and nonalbumin proteinuria on graft loss and death in renal transplant recipients. Am J Transplant (2007) 0.99
Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup. J Clin Microbiol (2005) 0.98
Fatal algaemia in patient with chronic lymphocytic leukemia. Emerg Infect Dis (2009) 0.96
Supernatant from bifidobacterium differentially modulates transduction signaling pathways for biological functions of human dendritic cells. PLoS One (2008) 0.92
Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women. Clin Infect Dis (2013) 0.92
Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant. Transplantation (2006) 0.91
mTOR inhibition: the learning curve in kidney transplantation. Transpl Int (2010) 0.91
Occupational exposure in ANCA-positive patients: a case-control study. Kidney Int (2005) 0.91
Heme oxygenase-1 inducer hemin attenuates the progression of remnant kidney model. Nephron Exp Nephrol (2009) 0.90
CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1. Mol Immunol (2008) 0.89
Follow-up after renal transplantation with organs from donors after cardiac death. Transpl Int (2006) 0.88
Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort. Diabetes Care (2014) 0.88
Mutations within the hepatitis C virus genotype 1b E2-PePHD domain do not correlate with treatment outcome. J Clin Microbiol (2005) 0.88
Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency. Circ Cardiovasc Genet (2011) 0.87
Center effect on ankle-brachial index measurement when using the reference method (Doppler and manometer): results from a large cohort study. Am J Hypertens (2009) 0.87
Expert consensus: Renal denervation for the treatment of hypertension. Diagn Interv Imaging (2012) 0.86
Mycophenolic acid-treated human dendritic cells have a mature migratory phenotype and inhibit allogeneic responses via direct and indirect pathways. Int Immunol (2005) 0.86
TCF7L2 polymorphism associates with new-onset diabetes after transplantation. J Am Soc Nephrol (2009) 0.86
Management of hypertension in adults: the 2013 French Society of Hypertension guidelines. Fundam Clin Pharmacol (2013) 0.86
Anti CD25 treatment of human dendritic cells modulates both their cytokine synthesis profiles and their capacity to activate allogeneic CD4 T cells: a potential tolerogenic effect. Int Immunopharmacol (2007) 0.85
Acute graft pyelonephritis: a potential cause of acute rejection in renal transplant. Transplantation (2005) 0.85
CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A. Nephrol Dial Transplant (2008) 0.84
New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity. Drugs (2014) 0.84
Molecular diagnosis of renal-allograft rejection: correlation with histopathologic evaluation and antirejection-therapy resistance. Transplantation (2004) 0.84
Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. J Heart Lung Transplant (2011) 0.84
[Autochthonous hepatitis E in France and consumption of raw pig meat]. Gastroenterol Clin Biol (2007) 0.84
Sequence and functional analysis of the envelope glycoproteins of hepatitis C virus variants selectively transmitted to a new host. J Virol (2013) 0.84
Expert consensus: renal denervation for the treatment of arterial hypertension. Arch Cardiovasc Dis (2012) 0.82
Acute septic arthritis after kidney transplantation due to Acremonium. Nephrol Dial Transplant (2003) 0.82
Significance of pretreatment analysis of hepatitis C virus genotype 1b hypervariable region 1 sequences to predict antiviral outcome. J Clin Microbiol (2003) 0.82
Heme oxygenase-1 inducer hemin prevents vascular thrombosis. Thromb Haemost (2007) 0.82
Introduction to the concept of functioning-dependent structures in living cells. C R Biol (2004) 0.82
Renal resistive index as a new independent risk factor for new-onset diabetes mellitus after kidney transplantation. Transpl Int (2012) 0.82
The Orai-1 and STIM-1 complex controls human dendritic cell maturation. PLoS One (2013) 0.82
Conversion to mTOR-inhibitor-based immunosuppression: which patients and when? Transplant Res (2013) 0.82
Campylobacter fetus subspecies fetus spondylodiscitis. J Med Microbiol (2010) 0.82
Use of an anti-hepatitis C virus (HCV) IgG avidity assay to identify recent HCV infection. J Clin Microbiol (2010) 0.81
Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: results of a randomized trial. Transpl Immunol (2013) 0.81
Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand. PLoS One (2012) 0.81
Ankle-brachial index and peripheral arterial disease. N Engl J Med (2010) 0.81
Hemin, a carbon monoxide donor, improves systemic vascular compliance by inhibiting the RhoA-Rhokinase pathway in spontaneous hypertensive rats. Eur J Pharmacol (2009) 0.81
Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplants. Clin Pharmacokinet (2002) 0.80
Induction of human CD4+ regulatory T cells by mycophenolic acid-treated dendritic cells. J Leukoc Biol (2008) 0.80
A role for CD2 antibodies (BTI-322 and its humanized form) in the in vivo elimination of human T lymphocytes infiltrating an allogeneic human skin graft in SCID mice: an Fcgamma receptor-related mechanism involving co-injected human NK cells. Transplantation (2004) 0.80
Higher exposure to mycophenolic acid with sirolimus than with cyclosporine cotreatment. Clin Pharmacol Ther (2005) 0.80
Analysis of human CD4 T lymphocyte proliferation induced by porcine lymphoblastoid B cell lines. Xenotransplantation (2003) 0.80
Association of donor TNFRSF6 (FAS) gene polymorphism with acute rejection in renal transplant patients: a case-control study. Nephrol Dial Transplant (2004) 0.80
Variability in creatinine excretion in adult diabetic, overweight men and women: consequences on creatinine-based classification of renal disease. Diabetes Res Clin Pract (2008) 0.80